SCHEMBL26035237

SCHEMBL26035237

Cc1ccc(NC(=O)c2ccc(N3CCN(C)CC3)nc2C)cc1-c1ccccn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF18A Q8NI77 1/20 0.53
L3MBTL1 Q9Y468 2/20 0.52
MAPT P10636 4/20 0.51
TP53 P04637 2/20 0.48
RAB9A P51151 2/20 0.48
MAPK14 Q16539 3/20 0.46
LCK P06239 2/20 0.46
KDR P35968 2/20 0.46
POLB P06746 1/20 0.45
KMT2A Q03164 1/20 0.45
RAF1 P04049 1/20 0.45
BRAF P15056 1/20 0.45
ALB P02768 1/20 0.44
HTR1A P08908 1/20 0.44
SLC6A2 P23975 1/20 0.44
PDE4A P27815 1/20 0.44
OPRM1 P35372 1/20 0.44
DRD3 P35462 1/20 0.44
HTR2B P41595 1/20 0.44
SLC6A3 Q01959 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26035247 0.91 KIF18A (0.53) KIF18AL3MBTL1MAPTMAPK14RAF1
SCHEMBL26037930 0.91 KIF18A (0.51) KIF18AL3MBTL1MAPTTP53RAB9A
SCHEMBL2611840 0.91 ALB (0.55) L3MBTL1MAPTALBHTR1ASLC6A2
SCHEMBL2619390 0.91 L3MBTL1 (0.48) KIF18AL3MBTL1MAPTTP53RAB9A
SCHEMBL26035242 0.90 KIF18A (0.52) KIF18AMAPK14RAF1BRAFALB
SCHEMBL26037949 0.89 KIF18A (0.51) KIF18ARAF1BRAFALBHTR1A
SCHEMBL26035218 0.89 KIF18A (0.49) KIF18AL3MBTL1MAPTRAF1BRAF
SCHEMBL26035211 0.89 KIF18A (0.49) KIF18AL3MBTL1MAPTRAF1BRAF
SCHEMBL26035226 0.89 KIF18A (0.53) KIF18AL3MBTL1MAPTMAPK14RAF1
SCHEMBL26035205 0.89 KIF18A (0.49) KIF18AL3MBTL1MAPTRAF1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265054-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING GENENTECH, INC. (US) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265054-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING SHH, GLI1, SMO KIF18A 3156/4885L3MBTL1 925/4885MAPT 3822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.